2000
DOI: 10.1002/(sici)1098-2299(200001)49:1<29::aid-ddr5>3.0.co;2-l
|View full text |Cite
|
Sign up to set email alerts
|

Model protocol to study pharmacogenomics in inflammatory diseases: Human rheumatoid arthritis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2002
2002
2004
2004

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 13 publications
0
2
0
Order By: Relevance
“…Another strategy to reduce targets to a manageable number would be by applying pharmacogenomic screens (in vitro and in vivo), and comparing the targets to chemogenomic databases during pharmacological intervention e.g. TNFα and/or recombinant TNF antagonists (Attur et al, 2000a).…”
Section: Gene Mining In Arthritismentioning
confidence: 99%
See 1 more Smart Citation
“…Another strategy to reduce targets to a manageable number would be by applying pharmacogenomic screens (in vitro and in vivo), and comparing the targets to chemogenomic databases during pharmacological intervention e.g. TNFα and/or recombinant TNF antagonists (Attur et al, 2000a).…”
Section: Gene Mining In Arthritismentioning
confidence: 99%
“…The cells are then packaged in an inert sponge together with normal human cartilage and implanted in a renal capsule in mice. This strategy has been utilized to examine the effect of IL-1Ra, p55-TNFα receptor, IL-10, tumor suppressors PTEN and p53 in cartilage degradation (Jorgensen and Gay, 1998;Attur et al, 2000a) .…”
Section: An In Vivo Model Of Scid Mouse For Human Synovium/ Cartilagementioning
confidence: 99%